Project
MSD MK1308A-004
Automatically Closed ยท 2021 until 2022
Stillhard Roman, Semela David, Bergamin Irina
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Automatically Closed
Start Date
2021
End Date
2022
Financing
Industry
Brief description/objective
Phase 2, Multicenter, Clinical Study to Evaluate the Safety and Efficacy of
MK-1308A (Coformulated MK-1308/MK-3475) in Combination with Lenvatinib (E7080/MK-7902) in First-line Therapy of Participants with Advanced Hepatocellular Carcinoma